Martha Neagu

Martha Neagu

Company: AbbVie

Job title: Associate Medical Director - Physician Development Program


Phase I Efficacy & Safety Study of Serclutamab Talirine, an EGFR Targeting Antibody Drug Conjugate, in Subjects with Recurrent Glioblastoma (GBM) 12:30 pm

• Review of targeting EGFR with antibody drug conjugates in solid tumors • Examine the efficacy and safety of Serclutamab Talirine in subjects with recurrent glioblastoma • Discuss conclusions and future directionsRead more

day: day 2 track 3

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.